Catalyst Wire Dossier Catalyst Wire Dossier

CVD 1000 Trivalent Invasive Salmonella Disease Vaccine

Salmonella conjugate vaccine (CVD 1000), trivalent · University of Maryland, Baltimore
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CVD 1000 Trivalent Invasive Salmonella Disease Vaccine, covering 2025-03-11 to 2025-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine [Phase 1]

See pricing